Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children

NCT04610125 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

BIOLOGICAL: Auto CAR-T
DRUG: Cyclophosphamide,Fludarabine
PROCEDURE: Leukapheresis

Sponsor

Hebei Senlang Biotechnology Inc., Ltd.

Collaborators

[object Object]